BRVO | CRVO | |||
---|---|---|---|---|
Ranibizumab | Laser Photocoagulation | Ranibizumab | Observation | |
Treatment visits | ||||
First Year | 7.0 | 1.4 | 8.2 | 0 |
Second Year | 2.1 | 0.3 | 3.5 | 0 |
Follow-up visits | ||||
First Year | 2.3 | 4.9 | 2 | 5.4 |
Second Year | 0.8 | 1.8 | 1.4 | 3 |
Third Year | 1.1 | 1 | 0.8 | 1.3 |
Fourth Year | 0.6 | 0.8 | 0.3 | 0.8 |
Fifth Year | 0.2 | 0.2 | 0.3 | 0.3 |